0000899243-19-025314.txt : 20191008 0000899243-19-025314.hdr.sgml : 20191008 20191008190400 ACCESSION NUMBER: 0000899243-19-025314 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191007 FILED AS OF DATE: 20191008 DATE AS OF CHANGE: 20191008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ray Nitya G. CENTRAL INDEX KEY: 0001709522 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 191143508 MAIL ADDRESS: STREET 1: 14 BAYBURY COURT CITY: EAST HANOVER STATE: NJ ZIP: 07936 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-07 0 0001175680 CytoDyn Inc. CYDY 0001709522 Ray Nitya G. 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 0 1 0 0 See Remarks Stock Options (right to buy) 0.39 2019-10-07 4 A 0 187500 0.00 D 2029-10-07 Common Stock 187500 187500 D The options will vest in twelve equal monthly installments over the one year period commencing on November 7, 2019. Chief Technology Officer Head of Process Sciences, Manufacturing and Supply Chain /s/ Michael D. Mulholland, as attorney-in-fact 2019-10-08